WO2021212066A2 - Vésicules extracellulaires rbc - Google Patents
Vésicules extracellulaires rbc Download PDFInfo
- Publication number
- WO2021212066A2 WO2021212066A2 PCT/US2021/027816 US2021027816W WO2021212066A2 WO 2021212066 A2 WO2021212066 A2 WO 2021212066A2 US 2021027816 W US2021027816 W US 2021027816W WO 2021212066 A2 WO2021212066 A2 WO 2021212066A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- rna
- cells
- exosomes
- cell
- evs
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
Abstract
L'invention concerne des compositions comprenant des vésicules extracellulaires, comme des exosomes, présentant une nanoparticule d'ARN à leur surface. La nanoparticule d'ARN peut diriger la vésicule extracellulaire vers une cellule donnée par l'intermédiaire d'une fraction de ciblage. La vésicule extracellulaire peut également comprendre un fragment fonctionnel, qui peut être utilisé dans le traitement ou le diagnostic.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063011733P | 2020-04-17 | 2020-04-17 | |
US63/011,733 | 2020-04-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2021212066A2 true WO2021212066A2 (fr) | 2021-10-21 |
WO2021212066A3 WO2021212066A3 (fr) | 2021-12-09 |
Family
ID=78084514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2021/027816 WO2021212066A2 (fr) | 2020-04-17 | 2021-04-16 | Vésicules extracellulaires rbc |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2021212066A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024006870A3 (fr) * | 2022-06-29 | 2024-04-11 | Massachusetts Institute Of Technology | Architectures à matrice d'acides nucléiques structurés |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022513311A (ja) * | 2018-09-21 | 2022-02-07 | シティー・ユニバーシティー・オブ・ホンコン | カーゴ積載細胞外小胞 |
-
2021
- 2021-04-16 WO PCT/US2021/027816 patent/WO2021212066A2/fr active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024006870A3 (fr) * | 2022-06-29 | 2024-04-11 | Massachusetts Institute Of Technology | Architectures à matrice d'acides nucléiques structurés |
Also Published As
Publication number | Publication date |
---|---|
WO2021212066A3 (fr) | 2021-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10590417B2 (en) | RNA ligand-displaying exosomes for specific delivery of therapeutics to cell by RNA nanotechnology | |
US20200208157A1 (en) | Rna ligand-displaying exosomes for specific delivery of therapeutics to cell by rna nanotechnology | |
Zhang et al. | Engineered exosomes from different sources for cancer-targeted therapy | |
US10301621B2 (en) | Multifunctional RNA nanoparticles and methods of use | |
US20100144845A1 (en) | Oligonucleotide systems for targeted intracellular delivery | |
US10517890B2 (en) | Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles | |
US20100016409A1 (en) | Rna Nanoparticles and Nanotubes | |
EP3204117A1 (fr) | Polarisation de macrophages vers un phénotype de cicatrisation par des cellules dérivées de la cardiosphère et par les exosomes sécrétés par ces cellules | |
US20190351071A1 (en) | Structures and methods for gene therapy | |
CN108175759A (zh) | 一种抗肿瘤靶向给药系统及其制备方法与应用 | |
US20210162066A1 (en) | Rna/dna hybrid nanoparticles modified with single stranded rna toeholds and uses thereof | |
KR20220144831A (ko) | 암호화 리보핵산의 기관 보호적 발현 및 조절을 위한 조성물 및 방법 | |
US20150203842A1 (en) | Co-transcriptional assembly of modified rna nanoparticles | |
Quadri et al. | Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy | |
Jurgielewicz et al. | Therapeutic potential of nucleic acids when combined with extracellular vesicles | |
US20160008431A1 (en) | Tumor Therapy With Antitumor Agents In Combination With Sindbis Virus-Based Vectors | |
Asakiya et al. | Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications | |
WO2021212066A2 (fr) | Vésicules extracellulaires rbc | |
AU2015290058B2 (en) | Methods and compositions comprising a ct20 peptide | |
US20230130754A1 (en) | Surface-modified exosomes and methods of use | |
US20210162076A1 (en) | Aptamer Compositions and Methods of Use Thereof | |
Dilsiz | Exosomes as new generation vehicles for drug delivery systems | |
Balcorta et al. | Nucleic Acid Delivery Nanotechnologies for In Vivo Cell Programming | |
WO2023117378A1 (fr) | Vésicules extracellulaires modifiées à administration de charge améliorée | |
CA3223463A1 (fr) | Procedes et materiaux pour le traitement du cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21789311 Country of ref document: EP Kind code of ref document: A2 |